GO:0006565 L-serine catabolic process: Metabolic Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006565 (L-serine catabolic process) describes the biochemical reactions that break down L-serine into pyruvate, ammonia, and one-carbon units, feeding glycolysis, gluconeogenesis, and methylation.
• The pathway is essential for neurotransmitter balance because L-serine is a precursor of glycine and D-serine, both of which modulate NMDA receptor activity.
• Key enzymes include serine dehydratase (SDS), serine hydroxymethyltransferase (SHMT1/2), and D-amino acid oxidase (DAO), which collectively regulate serine flux.
• Dysregulation of L-serine catabolism is linked to Alzheimer's disease, podocyte injury, and macrophage hyperinflammation, making it a therapeutic target.
• CRISPR knockout, point-mutation, and knock-in models are powerful tools to dissect the enzymatic steps and regulatory nodes of this pathway.
• Understanding L-serine catabolism provides insights into metabolic reprogramming in cancer, neurodegeneration, and immune responses.
Description
L-serine is a non-essential amino acid that serves as a central hub in cellular metabolism, contributing to protein synthesis, one-carbon metabolism, and neurotransmitter production. The catabolic process of L-serine, annotated as GO:0006565, encompasses the enzymatic reactions that convert L-serine into pyruvate, ammonia, and methylene tetrahydrofolate, thereby linking amino acid breakdown to energy production and biosynthetic pathways. This process is particularly important in the brain, where L-serine is synthesized in astrocytes and catabolized to support neuronal function and synaptic plasticity. Research over the past two decades has revealed that L-serine catabolism is not merely a housekeeping pathway but a tightly regulated process that influences cell fate, immune responses, and disease progression. For example, impaired glycolytic production of L-serine in astrocytes contributes to cognitive deficits in Alzheimer's disease, while enhanced serine catabolism in macrophages aggravates hyperinflammation during Pseudomonas aeruginosa pneumonia. These findings underscore the need for precise genetic models to study the pathway's components and regulation. This article provides a comprehensive overview of GO:0006565, integrating authoritative QuickGO annotations with verified PubMed literature. We cover the definition, core enzymatic steps, key genes, disease associations, and cutting-edge research methods, including CRISPR-based genome editing. By synthesizing this information, we aim to support researchers in designing experiments that elucidate the role of L-serine catabolism in health and disease.
L-serine catabolic process At A Glance
| GO ID | GO:0006565 |
|---|---|
| GO term | L-serine catabolic process |
| Ontology | biological_process |
| Synonym | L-serine breakdown, L-serine catabolism, L-serine degradation |
| Major function | Breakdown of L-serine to pyruvate, ammonia, and one-carbon units |
| Key enzymes | SDS, SHMT1, SHMT2, DAO, GLDH |
| Subcellular location | Cytosol, mitochondria, peroxisomes |
| Pathway links | Glycolysis, gluconeogenesis, one-carbon metabolism, neurotransmitter synthesis |
What Is GO:0006565?
The L-serine catabolic process (GO:0006565) is defined as the chemical reactions and pathways resulting in the breakdown of L-serine. This includes enzymatic deamination, dehydroxylation, and cleavage reactions that convert L-serine into simpler metabolites such as pyruvate, ammonia, and one-carbon units. The process is essential for amino acid homeostasis, energy production, and the generation of precursors for nucleotide synthesis and methylation reactions.
Why Is L-serine catabolic process Important in Cell Biology?
L-serine catabolism is critical for maintaining metabolic balance and supporting specialized cellular functions. In the central nervous system, it regulates the availability of L-serine for conversion to glycine and D-serine, which are essential co-agonists of NMDA receptors and influence synaptic transmission and cognitive processes. In peripheral tissues, the pathway contributes to gluconeogenesis and one-carbon metabolism, impacting cell proliferation and immune responses. Dysregulation of L-serine catabolism has been implicated in Alzheimer's disease, kidney injury, and inflammatory conditions, highlighting its broad physiological and pathological significance.
• Maintains amino acid homeostasis by preventing excessive accumulation of L-serine.
• Supplies pyruvate for gluconeogenesis and energy production.
• Generates one-carbon units for nucleotide synthesis and methylation reactions.
• Regulates neurotransmitter levels (glycine, D-serine) and NMDA receptor activity.
• Implicated in Alzheimer's disease through impaired astrocytic serine production.
• Associated with podocyte injury and senescence in kidney disease.
• Drives macrophage hyperinflammation in bacterial pneumonia.
• Potential target for cancer therapy via modulation of serine metabolism.
• Provides biomarkers for metabolic disorders and neurodegeneration.
• Enables mechanistic studies using CRISPR-edited cell and animal models.
What Happens During L-serine catabolic process?
Deamination of L-serine to pyruvate
In simple terms: L-serine is converted into pyruvate, releasing ammonia.
The first step in L-serine catabolism is the deamination of L-serine to pyruvate and ammonia, catalyzed by serine dehydratase (SDS) in the cytosol. This reaction links serine breakdown to glycolysis and gluconeogenesis, as pyruvate can enter the tricarboxylic acid cycle or be used for glucose synthesis. SDS expression is regulated by hormonal and nutritional signals, ensuring that serine catabolism meets cellular energy demands.
One-carbon unit generation via SHMT
In simple terms: L-serine is split to produce glycine and a one-carbon unit.
Serine hydroxymethyltransferase (SHMT1 in the cytosol and SHMT2 in mitochondria) catalyzes the reversible conversion of L-serine and tetrahydrofolate to glycine and 5,10-methylene tetrahydrofolate. This reaction is a major source of one-carbon units for nucleotide biosynthesis and methylation reactions. The catabolic direction of SHMT is favored when serine is in excess, contributing to the pool of glycine and folate intermediates.
Peroxisomal degradation by DAO
In simple terms: D-amino acid oxidase breaks down D-serine, which can be derived from L-serine.
Although D-amino acid oxidase (DAO) primarily acts on D-serine, it also contributes to L-serine catabolism indirectly by degrading D-serine produced from L-serine by serine racemase. DAO is localized in peroxisomes and generates hydrogen peroxide, which can influence redox signaling. This pathway is particularly relevant in the brain, where D-serine levels modulate NMDA receptor function.
Glutamate dehydrogenase and ammonia handling
In simple terms: Ammonia released from serine is detoxified by incorporating it into glutamate.
The ammonia produced by serine deamination is rapidly detoxified by glutamate dehydrogenase (GLDH), which catalyzes the reductive amination of alpha-ketoglutarate to glutamate. This reaction connects serine catabolism to nitrogen metabolism and prevents ammonia toxicity. In mitochondria, GLDH activity is tightly regulated by allosteric effectors and redox state.
Integration with glycolysis and TCA cycle
In simple terms: The products of serine breakdown feed into energy-producing pathways.
Pyruvate generated from serine can be oxidized in mitochondria to acetyl-CoA, which enters the TCA cycle to produce ATP and reducing equivalents. Alternatively, pyruvate can be converted to lactate or used for gluconeogenesis. This integration ensures that serine catabolism contributes to cellular energy balance and biosynthetic precursor supply, particularly in proliferating cells and neurons.
Key Genes Involved in GO:0006565 L-serine catabolic process
The following genes encode enzymes and transporters directly involved in L-serine catabolic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SDS | Serine dehydratase; converts L-serine to pyruvate and ammonia | Target for studying gluconeogenesis and serine flux |
| SHMT1 | Cytosolic serine hydroxymethyltransferase; produces glycine and one-carbon units | Key node in one-carbon metabolism and cancer |
| SHMT2 | Mitochondrial serine hydroxymethyltransferase; supports mitochondrial one-carbon metabolism | Linked to cell proliferation and redox balance |
| DAO | D-amino acid oxidase; degrades D-serine derived from L-serine | Modulates NMDA receptor activity in brain |
| GLDH | Glutamate dehydrogenase; detoxifies ammonia from serine deamination | Connects serine catabolism to nitrogen metabolism |
| SRR | Serine racemase; converts L-serine to D-serine | Regulates D-serine availability for neurotransmission |
| SLC1A4 | Neutral amino acid transporter; mediates L-serine uptake | Target for cancer therapy and metabolic studies |
| SLC7A5 | L-type amino acid transporter; transports L-serine and other large amino acids | Involved in mTOR signaling and cancer metabolism |
| PHGDH | Phosphoglycerate dehydrogenase; first step in L-serine synthesis | Serine synthesis pathway, not catabolism, but affects flux |
| PSAT1 | Phosphoserine aminotransferase; serine synthesis | Indirectly influences serine catabolism via substrate availability |
| PSPH | Phosphoserine phosphatase; serine synthesis | Regulates serine levels for catabolism |
| MTHFD1 | Methylenetetrahydrofolate dehydrogenase; links one-carbon metabolism | Interacts with SHMT1 in serine catabolism |
| MTHFD2 | Mitochondrial one-carbon enzyme; supports SHMT2 activity | Relevant in cancer and immune cells |
| GCSH | Glycine cleavage system H protein; involved in glycine catabolism | Connected to serine catabolism via glycine |
| GLDC | Glycine decarboxylase; catabolizes glycine produced from serine | Links serine catabolism to one-carbon pool |
| AMT | Aminomethyltransferase; part of glycine cleavage system | Supports serine catabolism downstream |
| DLD | Dihydrolipoamide dehydrogenase; component of glycine cleavage system | Redox regulation in serine catabolism |
How Is L-serine catabolic process Regulated?
L-serine catabolism is regulated at multiple levels, including enzyme expression, allosteric control, and substrate availability. The transcription of SDS is induced by glucagon and glucocorticoids during fasting, promoting serine conversion to pyruvate for gluconeogenesis. SHMT1 and SHMT2 are regulated by one-carbon status and mitochondrial redox signals, with SHMT2 expression often elevated in proliferating cells to support nucleotide synthesis. In the brain, serine racemase (SRR) activity determines the balance between L-serine catabolism and D-serine production, which is modulated by neuronal activity and neuroinflammation. Additionally, the mTOR pathway senses serine levels and can influence catabolic flux through downstream effectors, although direct phosphorylation of catabolic enzymes remains less characterized.
L-serine catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PHGDH | Alzheimer's disease; impaired serine synthesis | Astrocyte-specific knockout mice |
| SDS | Hyperglycemia; gluconeogenesis dysregulation | Liver-specific knockout mice |
| SHMT2 | Cancer; one-carbon metabolism | Cancer cell lines with SHMT2 knockout |
| SLC1A4 | Gastric cancer; serine uptake | Xenograft models with SLC1A4 inhibition |
| SRR | Schizophrenia; NMDA receptor hypofunction | SRR knockout mice |
Alzheimer's disease and cognitive deficits
Impaired glycolysis-derived L-serine production in astrocytes contributes to cognitive deficits in Alzheimer's disease. Le Douce et al. demonstrated that reduced serine synthesis leads to decreased L-serine availability for neuronal catabolism and neurotransmitter production, exacerbating synaptic dysfunction. This highlights the importance of astrocyte-neuron metabolic coupling in maintaining cognitive function.
Kidney podocyte injury and senescence
Impaired glycolysis-derived serine metabolism is a key driver of podocyte injury with senescence. Hu et al. showed that dysregulated serine catabolism in podocytes leads to cellular senescence and kidney dysfunction, suggesting that targeting this pathway could mitigate chronic kidney disease.
Macrophage hyperinflammation in pneumonia
Phosphoglycerate dehydrogenase-mediated serine reprogramming aggravates macrophage hyperinflammation in murine Pseudomonas aeruginosa pneumonia. Chen et al. found that enhanced serine catabolism promotes pro-inflammatory cytokine production, indicating a role for serine metabolism in immune responses.
Cancer metabolism and therapeutic targeting
Skullcapflavone II inhibits SLC1A4-mediated L-serine uptake and promotes mitochondrial damage in gastric cancer, demonstrating that disrupting serine uptake and catabolism can selectively kill cancer cells. This underscores the potential of targeting L-serine catabolic process in oncology.
From L-serine catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SDS loss impair gluconeogenesis? | SDS knockout hepatocytes or mice |
| How does SHMT2 deletion affect one-carbon flux? | SHMT2 knockout cancer cell lines |
| Can point mutation in SRR alter D-serine levels? | SRR point-mutation knock-in mice |
| Does SLC1A4 overexpression increase serine uptake? | SLC1A4 overexpression in gastric cancer cells |
| What is the effect of PHGDH knock-in on Alzheimer's? | PHGDH knock-in astrocytes |
| How does DAO tagging reveal subcellular localization? | DAO-GFP knock-in cells |
How to Study the L-serine catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Levels of serine, pyruvate, glycine, one-carbon metabolites | Quantifying pathway flux in cells |
| 13C-serine tracing | Catabolic flux through deamination and SHMT | Metabolic reprogramming studies |
| Enzyme activity assay | SDS, SHMT, DAO catalytic activity | Validating CRISPR knockouts |
| CRISPR knockout screen | Genes required for serine catabolism | Identifying novel regulators |
| Western blot | Protein expression of catabolic enzymes | Confirming knockout or overexpression |
| Immunofluorescence | Subcellular localization of enzymes | Mitochondrial vs cytosolic SHMT |
| Ribo-seq | Translation efficiency of catabolic genes | Translational regulation under stress |
| Seahorse assay | Oxygen consumption and glycolysis | Functional impact of serine catabolism |
Metabolomics and flux analysis
Metabolomics using mass spectrometry can quantify L-serine and its catabolic products (pyruvate, glycine, one-carbon units) in cells and tissues. Stable isotope tracing with 13C-labeled serine allows real-time flux analysis through the pathway, revealing how genetic perturbations affect catabolic rates.
Enzyme activity assays
Direct measurement of SDS, SHMT, and DAO activities in cell lysates provides biochemical validation of catabolic function. These assays use specific substrates and detect product formation via spectrophotometry or HPLC, enabling comparison between wild-type and CRISPR-edited cells.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes essential for L-serine catabolism under specific conditions, such as serine deprivation. Hits from these screens can be validated individually, linking candidate genes to pathway activity and cellular fitness.
Imaging and subcellular localization
Fluorescence microscopy of tagged enzymes (e.g., GFP-SHMT2) reveals their subcellular distribution and dynamic changes under metabolic stress. Live-cell imaging can track serine catabolism in real time using genetically encoded biosensors.
How CRISPR Can Be Used to Study GO:0006565 L-serine catabolic process
Knockout
CRISPR knockout of SDS, SHMT1, SHMT2, or DAO in cell lines or mice abolishes specific catabolic steps, allowing researchers to measure compensatory pathways and metabolic rewiring. For example, SHMT2 knockout in cancer cells reduces one-carbon units and impairs proliferation.
Point Mutation
Introducing point mutations in catalytic residues of SDS or SHMT (e.g., active-site serine to alanine) via CRISPR base editing or HDR can dissect enzymatic mechanisms without completely eliminating protein expression. Such models are valuable for studying partial loss-of-function in disease.
Knock-in
Knock-in of fluorescent tags (e.g., GFP, mCherry) at endogenous loci enables real-time tracking of enzyme localization and dynamics. Tagged SHMT2 knock-in cells have been used to visualize mitochondrial one-carbon metabolism.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of SDS or SHMT can enhance serine catabolism, modeling conditions of metabolic excess. Overexpression of SLC1A4 increases serine uptake and can sensitize cancer cells to serine deprivation.
How EDITGENE Supports L-serine catabolic process Research
Researchers studying L-serine catabolic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease progression, or therapeutic response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional validation of genes such as SDS, SHMT1/2, DAO, and SLC1A4.
Contact EDITGENE today to design your custom CRISPR model for L-serine catabolic process research.
Frequently Asked Questions About L-serine catabolic process
What is L-serine catabolic process?
L-serine catabolic process (GO:0006565) is the set of biochemical reactions that break down L-serine into pyruvate, ammonia, and one-carbon units, linking amino acid metabolism to energy production and biosynthesis.
What genes are involved in L-serine catabolic process?
Key genes include SDS, SHMT1, SHMT2, DAO, GLDH, and SRR, which encode enzymes that catalyze the deamination, hydroxymethylation, and oxidation of L-serine.
How is L-serine catabolism regulated?
It is regulated by enzyme expression (e.g., SDS induction by glucagon), substrate availability, and one-carbon status, with SHMT2 often upregulated in proliferating cells.
What diseases are linked to L-serine catabolic process?
Dysregulation is associated with Alzheimer's disease, kidney podocyte injury, macrophage hyperinflammation, and cancer, making it a therapeutic target.
Which enzymes catalyze L-serine breakdown?
Serine dehydratase (SDS) converts L-serine to pyruvate, while serine hydroxymethyltransferase (SHMT1/2) produces glycine and one-carbon units.
How can CRISPR be used to study L-serine catabolism?
CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of gene function in the pathway, from enzymatic mechanisms to disease phenotypes.
What is the role of L-serine catabolism in the brain?
It regulates the production of glycine and D-serine, which are co-agonists of NMDA receptors and influence synaptic plasticity and cognition.
Is L-serine catabolism involved in cancer?
Yes, cancer cells often reprogram serine metabolism, and targeting serine uptake or catabolism can inhibit tumor growth, as shown in gastric cancer models.
What methods are used to study L-serine catabolic process?
Common methods include metabolomics, isotope tracing, enzyme activity assays, CRISPR screens, and imaging of tagged enzymes.
Can L-serine catabolism be targeted therapeutically?
Preclinical studies suggest that modulating serine catabolism may benefit Alzheimer's disease, kidney injury, and inflammatory conditions, though clinical trials are needed.
Conclusion
L-serine catabolic process (GO:0006565) is a fundamental metabolic pathway that connects amino acid breakdown to energy production, one-carbon metabolism, and neurotransmitter synthesis. Its dysregulation contributes to a range of diseases, including Alzheimer's disease, kidney injury, and cancer, making it a compelling target for therapeutic intervention. Advances in CRISPR genome editing and metabolic profiling now allow researchers to dissect the pathway with unprecedented precision. By leveraging EDITGENE's comprehensive CRISPR services, scientists can generate knockout, point-mutation, knock-in, and overexpression models to validate gene function and identify novel drug targets. This integrated approach will accelerate the translation of L-serine catabolism research into clinical benefits.
References
- 1. Le Douce J et al.. 2020. Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer's Disease.. Cell Metab 31(3):503-517.e8 PMID: 32130882
- 2. Zhao J et al.. 2025. Skullcapflavone II Inhibits SLC1A4-Mediated L-Serine Uptake and Promotes Mitochondrial Damage in Gastric Cancer.. Adv Sci (Weinh) 12(45):e17225 PMID: 40971730
- 3. Maugard M et al.. 2021. l-Serine links metabolism with neurotransmission.. Prog Neurobiol 197:101896 PMID: 32798642
- 4. Fernández-Moncada I et al.. 2024. A lactate-dependent shift of glycolysis mediates synaptic and cognitive processes in male mice.. Nat Commun 15(1):6842 PMID: 39122700
- 5. de Koning TJ et al.. 2003. L-serine in disease and development.. Biochem J 371(Pt 3):653-61 PMID: 12534373
- 6. Murtas G et al.. 2020. L-serine synthesis via the phosphorylated pathway in humans.. Cell Mol Life Sci 77(24):5131-5148 PMID: 32594192
- 7. Hu H et al.. 2025. Impaired glycolysis-derived serine metabolism as a key driver of podocyte injury with senescence.. Nat Commun 17(1):138 PMID: 41345115
- 8. Chen R et al.. 2026. Phosphoglycerate dehydrogenase-mediated serine reprogramming aggravates macrophage hyperinflammation in murine Pseudomonas aeruginosa pneumonia.. Nat Commun 17(1) PMID: 41720766
